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Assessment and Optimization of Medical 
Risks Using the Integrated Medical Model
1.  HRP Risk
The inability to treat an ill or injured crew member
2.  Problem
The inability to adequately reduce crew health risks via an in-flight 
medical system within operational constraints
3.  Objectives
• Enable evidence-based, risk-informed decisions by the HRP 
community in the context of crew profiles and mission 
constraints
• Enable evidence-based, risk informed decisions by the flight 
surgeon community in the context of crew and mission profiles
• Provide comparative risk assessments among crew and mission 
profiles
• Identify the medical equipment, pharmaceuticals, and 
consumables that most influence the decrease of mission health 
risks
• Optimize the allocation of medical resources for a given mass, 
volume, power, cost and level of acceptable risk
• Communicate comparative risk assessments effectively with 
operational programs
4.  Fundamental Questions
For a specified mission scenario:
• What medical conditions can be expected to occur?
• How many occurrences of these medical conditions can be 
expected?
• What medical conditions can be expected to have the most impact 
on crew health?
• What medical resources are most likely to be utilized?
• What is the probability of loss of crew life or evacuation due to 
medical events?
• What is the expected crew functional impairment?
• What are the optimal medical resources to minimize crew 
functional impairment and the probability of evacuation or loss of 
crew life?
5.  Outputs
A comparative analysis of missions, forecasts of medical events, 
estimates of risk to crew health and projections of  resource usage.
6.  Inputs
Consists of mission specific parameters and crew profiles.
Objective
Develop an evidence-based, probabilistic risk forecasting model 
that can help guide mission planning, requirements development, 
and align science with engineering technology development.
Scope
• The IMM forecasts medical outcomes for in-flight 
operations only and medical impacts to the mission
• Optimizes in-flight mass, volume, power for a given crew 
and mission profile
• Does not assess long-term or chronic medical impacts of 
crew health
Approach
• Uses ISS resources as medical capabilities. 
• Evidence based clinical research methods
• Probabilistic risk assessment techniques while    
collaborating with other NASA centers.
Example 2 – On a six month mission, is the amount of 
Ibuprofen sufficient if crew size is increased from 
three to six crew members?
Most Frequent Medical Conditions 
requiring Ibuprofen
1) Back injury
2) Sprain/Strain - Shoulder
3) Paresthesia
4) Back pain (SAS)
5) Sprain/Strain – Elbow
Mission A has                         
3 Crew Members
Mission B  has                                
6 Crew Members
Decision Support -Topics to be addressed
• Medical system requirements 
• Crew health and mission risk
How should the mix of medical system contents change for a  crew of 6 
(4 male, 2 female) for mission durations of 4  weeks, 6 months, 12 months, 
and 3 years?
Comparative Analysis - Crew Health Index (CHI)
Mission A  has 3 
Crew Members                                                     
Mean CHI is 74%
INPUTS
 Medical Conditions & 
Incidence Data
 Crew Profile
 Mission Profile & Constraints
 Potential Crew Functional 
Impairments
 Potential Mission End States
 In-flight Medical Resources
IMM
OUTPUT of Distributions
 Medical Condition 
Occurrences
 Crew Impairment
 Clinical End States
 Mission End States
 Resource Utilization
 Optimized Medical System
IMM uses Monte Carlo 
simulations to generate 
estimates of outcomes of 
interest.  Each simulation 
may require 10-25,000 “trial” 
missions to reach 
convergence.
Medical Event!
Best-case Scenario Worst-case Scenario
Decrement Medical Resources
Were the medical 
resources sufficient?
Yes No
Yes
Best-case Outcome Worst-case Outcome
Untreated Outcome
No
Example: Compare the number and type of medical events for similar 
missions but with different crews; Mission duration is 6 months, 3 EVA’s, 
ISS Medical Capabilities
Expect greater variation 
in the number of events
Mission B has 6 Crew  Members  (4M, 2F)
Mean 94.7 Medical Events
Mission A has 3 Crew  Members   (2M,1 F)
Mean 47.5 Medical Events
Sensitivity Analysis – Which of the 80+ medical conditions represented in 
IMM influence crew health most?
Mission A:                                      
3 Crew 
Members
Formulating the Conceptual Model of IMM
Expect about 
twice as many 
medical  events
Mission B:                                      
6 Crew 
Members
Increasing the size of the crew only changes 
the number of events, not the type of events
Medical Event Type
Medical Event Type
Mission B  has 6 Crew Members                                                    
Mean CHI is 48.8%
Quantity of 
Ibuprofen is 
insufficient 
for 2.0% of 
the trials
Quantity of 
Ibuprofen is 
insufficient for 
45.0% of the 
trials
The medical 
conditions that 
require Ibuprofen do 
not change due to 
crew size
Next Steps
• IMM Database Development
• Selection of long-term software technology platform
• External Verification & Validation; Non-Advocate Review (NAR)
• Configuration Management of Clinical Data Inputs
• ISS Medical System Re-design Support
• Constellation Program Health System Requirements Support
Doubling crew size without adjusting medical capabilities 
results in a 34% decrease in CHI, representing a relative 
increase in crew health risk comparing Mission A to Mission B.
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